bg-img9.jpg
8.jpg
Phacilitate Cell and Gene Therapy World 2017: Streamline the path from discovery to cure


The advancements in cell and gene therapy are increasing at a rapid pace and are transforming the way we think about medicine. Whether in research or in the clinic, scientific innovators are acutely aware that every moment counts when working with these valuable therapies. To facilitate knowledge sharing and collaboration, Thermo Fisher Scientific is proud to support Phacilitate Cell & Gene Therapy World 2017 as the Platinum Sponsor.

Topic: Cell Therapy Solutions, Content: Blog

Expanding our Global Footprint: Supporting Cell and Gene Therapy in Japan

As I mentioned in my previous blog, favorable regulations in Japan are impacting cell therapy clinical trials conducted by the biopharmaceutical industry on a global scale.  To meet this increasing demand Fisher BioServices has expanded our cryogenic service capabilities in Tokyo, Japan.  This expansion enables our customers to seamlessly conduct clinical trials across multiple geographies and provide patients around the world with access to life changing therapies. 

Topic: Cell Therapy Solutions, Content: Blog

Cell Therapy Clinical Trials and the Mad Dash to Japan

When Shinzo Abe was re-elected as Japan's Prime Minister he aggressively embarked on a challenge to revive Japan's struggling economy. With the introduction of Abenomics, an economic policy that includes "three arrows" of fiscal stimulus, monetary easing, and structural reforms, the ball was set in motion to redefine Japan's standings within the global market.

Topic: Cell Therapy Solutions, Content: Blog

Exploring Immunotherapies to Treat Crohn's Disease

Crohn’s disease and ulcerative colitis affect more than 1.6 million Americans, according to the Crohn’s and Colitis Foundation of America. Unfortunately, patients with Crohn’s disease are left with limited treatment options and no cure for the condition. This could change with new research supporting the use of immunotherapies to treat Crohn’s disease.

Topic: Cell Therapy Solutions, Content: Blog